European Society for Medical Oncology Advanced Course on Cholangiocarcinoma Where Are We Going 2023 Barcelona
Format: 13 videos + 14 pdfs, size: 1.04 GB
Course Audience: oncologist
Overview:
- Start date: 15 Sep 2023
- End date: 16 Sep 2023
- Location: Barcelona, Spain
Learning objectives
- To understand diagnostic challenges and clinical and molecular differences in cholangiocarcinoma
- To review adjuvant and palliative treatment strategies in patients with cholangiocarcinoma
- To discuss the role of locoregional therapy for cholangiocarcinoma
- To investigate the role of immunotherapy for the management of cholangiocarcinoma
- To explore currently available and novel targeted therapies and treatment options for advanced disease
ESMO-Advanced-Course-on-Cholangiocarcinoma-Where-Are-We-Going-2023-Barcelona-Programme (PDF Format)
Session 1 Patient Perspective What Should the Oncologist Treating Cholangiocarcinoma Take into Account (Video MP4 Format)Session 1 Patient Perspective What Should the Oncologist Treating Cholangiocarcinoma Take into Account (PDF Format)Session 1 Symptom Management When Treating Patients with Cholangiocarcinoma (Video MP4 Format)Session 1 Symptom Management When Treating Patients with Cholangiocarcinoma (PDF Format)Session 1 What is Cholangiocarcinoma (Primary Site, Molecular Biology, Epidemiology) (Video MP4 Format)Session 1 What is Cholangiocarcinoma (Primary Site, Molecular Biology, Epidemiology) (PDF Format)Session 2 Adjuvant Treatment Is Capecitabine the Standard of Care (Video MP4 Format)Session 2 Adjuvant Treatment Is Capecitabine the Standard of Care (PDF Format)Session 2 Neoadjuvant Treatment Is Perioperative Treatment Coming or Could it Have a Role (Video MP4 Format)Session 2 Neoadjuvant Treatment Is Perioperative Treatment Coming or Could it Have a Role (PDF Format)Session 3 Locoregional Therapies How Can we Improve the Study Design (Video MP4 Format)Session 3 Locoregional Therapies How Can we Improve the Study Design (PDF Format)Session 4 Chemotherapy First Line and Second Line. How is the Field Moving Forward (Video MP4 Format)Session 4 Chemotherapy First Line and Second Line. How is the Field Moving Forward (PDF Format)Session 4 Immunotherapy Rationale, Current Data and Upcoming Studies (Video MP4 Format)Session 4 Immunotherapy Rationale, Current Data and Upcoming Studies (PDF Format)Session 5 Ongoing Clinical Trials – Ongoing and Soon-to-Come Phase II and Phase III To Which Trials Shall I Recruit my Patients (Video MP4 Format)Session 5 Ongoing Clinical Trials – Ongoing and Soon-to-Come Phase II and Phase III To Which Trials Shall I Recruit my Patients (PDF Format)Session 5 Targeted Therapies Beyond FGFR and IDH Current Data and Compounds in Advanced (Phase II and Beyond) Stage of Development (Video MP4 Format)Session 5 Targeted Therapies Beyond FGFR and IDH Current Data and Compounds in Advanced (Phase II and Beyond) Stage of Development (PDF Format)Session 5 Targeted Therapies FGFR and IDH Current Data and Compounds in Advanced (Phase II and Beyond) Stage of Development (Video MP4 Format)Session 5 Targeted Therapies FGFR and IDH Current Data and Compounds in Advanced (Phase II and Beyond) Stage of Development (PDF Format)Session 5 What is Coming – Phase I Input – Novel IO Strategies, Cell Therapy New Compounds in Phase I with Potential Activity (Video MP4 Format)Session 5 What is Coming – Phase I Input – Novel IO Strategies, Cell Therapy New Compounds in Phase I with Potential Activity (PDF Format)Welcome and Introduction (Video MP4 Format)Welcome and Introduction (PDF Format)